|
|
|
|
-Sheet in Divalent Cation Modulation of
7 Nicotinic Receptors
Departments of Pharmacology (J.T.M., J.F., A.D.S., R.L.R.) and Cell & Molecular Physiology (R.L.R.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
-7 Nicotinic acetylcholine receptors (AChRs) exhibit a positive modulation by divalent cations similar to that observed in other AChRs. In the chick
7 AChR, this modulation involves a conserved glutamate in loop 9 (Glu172) that undergoes agonist-dependent movements during activation. From these observations, we hypothesized that movements of the nearby
-sheet formed by the
7,
9, and
10 strands may be involved in agonist activation and/or divalent modulation. To test this hypothesis, we examined functional properties of cysteine mutations of the
7 and
10 strands, alone or in pairs. We postulated that reduced flexibility or mobility of the
7/
9/
10-sheet as a result of introduction of a disulfide bond between the
strands would alter activation by agonists. Using a nondesensitizing
7 mutant background (L247T), we identified one mutant pair, K144C + T198C, that exhibited a unique characteristic: it was fully activated by divalent cations (Ca2+, Ba2+, or Sr2+) in the absence of acetylcholine (ACh). Divalent-evoked currents were blocked by the
7 antagonist methyllycaconitine and were abolished when Glu172 was mutated to glutamine. When the K144C + T198C pair was expressed in wild-type
7 receptors, activation required both ACh and divalent cations. We conclude that the introduction of a disulfide bond into
7/
9/
10 lowers the energetic barrier between open and closed conformations, probably by reducing the torsional flexibility of the
-sheet. In this setting, divalent cations, acting at the conserved glutamate in loop 9, act as full agonists or requisite coagonists.
Received for publication February 7, 2006.
Accepted for publication March 13, 2006.
Address correspondence to: Dr. James T. McLaughlin, Department of Pharmacology, CB# 7365, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365. E-mail: jmclaughlin{at}unc.edu
Related articles in MolPharm:
This article has been cited by other articles:
![]() |
S. C. Barron, J. T. McLaughlin, J. A. See, V. L. Richards, and R. L. Rosenberg An Allosteric Modulator of {alpha}7 Nicotinic Receptors, N-(5-Chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea (PNU-120596), Causes Conformational Changes in the Extracellular Ligand Binding Domain Similar to Those Caused by Acetylcholine Mol. Pharmacol., August 1, 2009; 76(2): 253 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bertrand, S. Bertrand, S. Cassar, E. Gubbins, J. Li, and M. Gopalakrishnan Positive Allosteric Modulation of the {alpha}7 Nicotinic Acetylcholine Receptor: Ligand Interactions with Distinct Binding Sites and Evidence for a Prominent Role of the M2-M3 Segment Mol. Pharmacol., November 1, 2008; 74(5): 1407 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Venkatachalan and C. Czajkowski A conserved salt bridge critical for GABAA receptor function and loop C dynamics PNAS, September 9, 2008; 105(36): 13604 - 13609. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Gay and J. L. Yakel Gating of nicotinic ACh receptors; new insights into structural transitions triggered by agonist binding that induce channel opening J. Physiol., November 1, 2007; 584(3): 727 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. McLaughlin, J. Fu, and R. L. Rosenberg Agonist-Driven Conformational Changes in the Inner beta-Sheet of {alpha}7 Nicotinic Receptors Mol. Pharmacol., May 1, 2007; 71(5): 1312 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsuneki, S. Kobayashi, K. Takagi, S. Kagawa, M. Tsunoda, M. Murata, T. Matsuoka, T. Wada, M. Kurachi, I. Kimura, et al. Novel G423S Mutation of Human {alpha}7 Nicotinic Receptor Promotes Agonist-Induced Desensitization by a Protein Kinase C-Dependent Mechanism Mol. Pharmacol., March 1, 2007; 71(3): 777 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lindstrom Potentiation of Acetylcholine Receptors by Divalent Cations Mol. Pharmacol., July 1, 2006; 70(1): 5 - 7. [Abstract] [Full Text] [PDF] |
||||